|

Fludarabine + Cyclophosphamide combination Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since July 2026

Also known as: Fludara; Cytoxan

Pipeline

Phase 1: 1

Top Sponsors

  • University of Pennsylvania1

Indications

  • Cholangiocarcinoma1
  • Pancreatic Adenocarcinoma1
  • Colorectal Cancer1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Philadelphia, Pennsylvania1 trial

TCR1188-ABC Cells in KRAS-mutated Cancers

University of Pennsylvania

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.